Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. Paris-based Sanofi is investing in a U.S. biotech’s autoimmune research, while GSK has…
Sanofi has dropped its respiratory syncytial virus (RSV) vaccine for toddlers after the candidate underperformed in a phase 3 study. The French Big Pharma was evaluating the intranasal live attenuated…
University of Michigan spinout Evoq Therapeutics has struck its third major partnership with a biopharma powerhouse, signing on with Sanofi in a deal worth up to $500 million. Without revealing…
Sanofi has become the latest Big Pharma to freeze R&D investment decisions in the U.K., while Roche confirmed it is staying put—for now. The news that Sanofi won’t consider “any…